rs758723288
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_004092.4(ECHS1):c.160C>T(p.Arg54Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,613,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R54S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004092.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECHS1 | NM_004092.4 | c.160C>T | p.Arg54Cys | missense_variant | 2/8 | ENST00000368547.4 | NP_004083.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECHS1 | ENST00000368547.4 | c.160C>T | p.Arg54Cys | missense_variant | 2/8 | 1 | NM_004092.4 | ENSP00000357535 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152232Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249548Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135294
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460910Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 726724
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152232Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 15, 2023 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg54 amino acid residue in ECHS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26000322, 32013919). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ECHS1 protein function. ClinVar contains an entry for this variant (Variation ID: 369670). This missense change has been observed in individual(s) with clinical features of mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (PMID: 26938784; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs758723288, gnomAD 0.004%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 54 of the ECHS1 protein (p.Arg54Cys). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 27, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28832562, 26938784, 29453417) - |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 05, 2015 | This homozygous variant is predicted to create a change of an arginine to a cysteine at position 954, NP_004083.3(ECHS1): p.(Arg54Cys). The arginine at this position is highly conserved. Grantham assessment is likely deleterious due to conservation and amino acid properties. In-silico software predicts this substitution to be deleterious. This variant is novel; however, another variant which results in the same amino acid being substituted has been reported as pathogenic (Haack et al 2015). This homozygous variant was also identified in another affected sibling in this family. Urine testing identified raised levels of 2,3-dihydroxy-1-methylbutyric acid and S-(2-carboxypropyl)cysteine, consistent with the diagnosis of ECHS1 deficiency. - |
ECHS1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The ECHS1 c.160C>T variant is predicted to result in the amino acid substitution p.Arg54Cys. This variant has been reported in the homozygous state in an individual with mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (Table S1, Stark et al. 2016. PubMed ID: 26938784; Table S1, Stark et al. 2017. PubMed ID: 28832562; Table S1, Dillon et al. 2018. PubMed ID: 29453417). This variant is reported in 4 of ~281,000 alleles in gnomAD. An alternate nucleotide change affecting the same amino acid (p.Arg54His) has also been reported in the compound heterozygous state in four unrelated individuals with mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (Table 1, Families F4, F8, and F9, Haack et al. 2015. PubMed ID: 26000322; Table 1, Yang et al. 2020. PubMed ID: 32013919 ). The c.160C>T (p.Arg54Cys) variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at